HansBiomed Corporation (KOSDAQ:042520)
7,670.00
+80.00 (1.05%)
At close: Aug 28, 2025
HansBiomed Revenue
HansBiomed had revenue of 24.16B KRW in the quarter ending March 31, 2025, with 18.10% growth. This brings the company's revenue in the last twelve months to 84.36B, up 7.75% year-over-year. In the fiscal year ending September 30, 2024, HansBiomed had annual revenue of 81.14B with 3.98% growth.
Revenue (ttm)
84.36B
Revenue Growth
+7.75%
P/S Ratio
1.16
Revenue / Employee
325.38M
Employees
263
Market Cap
99.61B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 81.14B | 3.11B | 3.98% |
Sep 30, 2023 | 78.03B | 3.57B | 4.80% |
Sep 30, 2022 | 74.46B | 15.36B | 25.99% |
Sep 30, 2021 | 59.10B | -21.00B | -26.22% |
Sep 30, 2020 | 80.10B | 13.11B | 19.57% |
Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.16T |
Samsung Biologics | 5,031.69B |
Hyundai Motor Company | 182.25T |
Hanwha Aerospace | 19.25T |
HD Hyundai Heavy Industries | 15.58T |
Doosan Enerbility | 16.30T |